Skip to main content
. Author manuscript; available in PMC: 2015 Dec 31.
Published in final edited form as: Am J Perinatol. 2015 Mar 2;32(10):973–979. doi: 10.1055/s-0035-1545666

Table 3.

Comparison of demographic and perinatal characteristics between infants with and without cPVL on screening imaging

Characteristics All infants < 1,000 g or
< 29 wks without
cPVL, N = 12,075
Cystic PVL with CA
criterion but not with
PMA criterion, N = 95
p Value
Birth weight (g), mean ± SD 864 ± 210 835 ± 208 0.18
Gestation (wks), mean ± SD 26.4 ± 1.8 25.4 ± 1.6 < 0.0001a
Male 6,260 (51.9) 46 (48.4) 0.50
PIH 428 (31.3) 2 (15.4) 0.37b
APH 219 (16.0) 6 (46.2) 0.004a
Any prenatal steroid 1,236 (10.2) 12 (12.6) 0.44
Complete course of steroid 977 (79.3) 6 (50.0) 0.01a
Maternal antibiotics < 72 h of delivery 923 (92.7) 8 (88.9) 0.67
Apgar score ≤ 3 at 1 min 11,271 (93.3) 91 (95.8) 0.53b
Apgar score ≤ 3 at 5 min 10,837 (89.8) 84 (88.4) 0.67
Delivery room bag and mask 1,052 (77.0) 13 (100.0) < 0.05a,b
DR chest compression 76 (5.6) 1 (7.7) 0.99b
BPD (O2 at 36 wks) 2,424 (47.3) 13 (59.1) 0.27
Steroids for BPD 1,686 (14.1) 9 (9.7) 0.23
Late-onset culture-proven sepsis 4,009 (33.2) 39 (41.1) 0.11
Ventilator days, mean ± SD 23.3 ± 26.7 34.3 ± 28.8 0.0004a

Abbreviations: APH, antepartum hemorrhage; BPD, bronchopulmonary dysplasia; CA, chronological age; cPVL, cystic periventricular leukomalacia; DR, delivery room; PIH, pregnancy-induced hypertension; PMA, postmenstrual age; PVL, periventricular leukomalacia; SD, standard deviation.

Note: The percentages are based on nonmissing responses in the registry. The percentages for the complete course of prenatal steroid are among those exposed to any prenatal steroid.

a

Significantly different at an α level of 0.05. Percentages were tested with a chi-square test, and means were tested with a t-test.

b

Tested with Fisher exact test. Values are percent and means; CA criterion: Cranial ultrasound within 28 d, PMA criterion: Screening neuroimaging closest to 36 weeks.